Dreyfus/The Boston Company Small/Mid Cap Growth Fund

  • Ticker: DBMYX
  • Product Code: 0187
  • CUSIP: 26203E653
Share Class:

Portfolio Manager/Sub-Investment Adviser

The fund's investment adviser is The Dreyfus Corporation (Dreyfus), and the fund's subadviser is The Boston Company Asset Management, LLC (TBCAM), an affiliate of Dreyfus. Todd W. Wakefield, CFA, and Robert C. Zeuthen, CFA, are the fund's primary portfolio managers, positions they have held since September 2005 and April 2013, respectively. Mr. Wakefield is a senior managing director, senior portfolio manager and a member of the U.S. small, small/mid and mid-cap growth investment team at TBCAM. Mr. Zeuthen is a managing director, senior equity research analyst and a member of the U.S. small, small/mid and mid-cap growth investment team at TBCAM.

Sector & Allocation 1

Top Holdings 2

IShares Russell 2000 Growth ETF 3.01%
Synopsys 2.40%
Align Technology 2.12%
Mellanox Technologies 2.05%
Snap-On 2.01%
Bemis Company 2.00%
IMAX 1.96%
EMCOR Group 1.93%
Integrated Device Technology 1.85%
Ligand Pharmaceuticals, Cl. B 1.82%

Portfolio Statistics

Benchmark 3 Russell 2500 Growth Index
Number of Holdings 73
as of 10/31/15
Portfolio Turnover Rate 144.39%
as of fiscal year end 09/30/15
P/E Ratio 4 26.88
as of 09/30/15

Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or a summary prospectus, if available, that contains this and other information about the fund, and read it carefully before investing.

Notes & Disclosures
  1. Portfolio composition and allocation is as of 10/31/15 and is subject to change at any time. Totals may not be exact due to rounding. Negative exposures may represent short positions through derivatives.
  2. The holdings listed should not be considered recommendations to buy or sell a security. Large concentrations can increase share price volatility.
  3. Source: Morningstar, Inc. All rights reserved. Reflects reinvestment of dividends and, where applicable, capital gain distributions. The Russell 2500 Growth Index is an unmanaged index, which is the funds benchmark index, that measures the performance of those Russell 2500 companies (the 2,500 smallest companies in the Russell 3000 Index (which is comprised of the 3,000 largest U.S. companies based on total market capitalization)) with higher price-to-book ratios and higher forecasted growth values.
  4. Price/earnings for a stock is the ratio of the company's most recent month-end share price to the company's estimated earnings per share (EPS) for the current fiscal year. If a third-party estimate for the current year EPS is not available, Morningstar will calculate an internal estimate based on the most recently reported EPS and average historical earnings growth rates. Price/ earnings is one of the five value factors used to calculate the Morningstar Style Box. For portfolios, this historical P/E data point is calculated by taking an asset-weighted average of the earnings yields (E/P) of all the stocks in the portfolio and then taking the reciprocal of the result. Source: Morningstar
Choose a date range

Quick Links